Dialysis News and Research

Latest Dialysis News and Research

CMS unveils updated website to help consumers compare quality data

Officials from the Centers for Medicare and Medicaid Services said Friday that site includes updated data to help consumers compare hospitals, physicians, nursing homes, home care or dialysis providers.

8 Aug 2011

Pre-emptive insulin therapy reduces risk of diabetes mellitus after kidney transplantation

Up to 30 percent of all patients develop diabetes mellitus within the first year after a kidney transplantation. This high rate could soon fall rapidly. A Medical University of Vienna research team at Vienna General Hospital's University Department of Internal Medicine III has discovered in the context of a study that pre-emptive insulin therapy drastically reduces this rate.

8 Aug 2011

NxStage second quarter revenue increases 22% to $53.8 million

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record financial results for the second quarter of 2011 ended June 30, 2011, with total revenue well above the top end of its guidance range.

3 Aug 2011

Roundup: Atlanta hospital facing questions about extending dialysis care to immigrants; Fla. to limit HMO choices for state workers

The agreement providing dialysis for immigrants who were former Grady patients expires at the end of August, and it's unclear what will happen next. ... Grady's financial situation has deteriorated recently, and its losses this year could reach $20 million or more. Meanwhile, the hospital continues to shoulder an enormous financial burden in caring for uninsured patients, including immigrants, providing more than $200 million in indigent care annually.

3 Aug 2011

Study shows fall in blood pressure during dialysis for patients increases risk of blood clotting

A sudden drop in blood pressure while undergoing dialysis has long vexed many kidney patients. Side effects associated with this situation over the long term range from stroke to seizure to heart damage to death.

30 Jul 2011

Amgen reports 8% increase in second quarter total product sales to $3,893 million

Amgen reported total revenue increased 4 percent during the second quarter of 2011 to $3,959 million versus $3,804 million in the second quarter of 2010. Total product sales increased 8 percent in the second quarter of 2011 to $3,893 million versus $3,613 million in the second quarter of 2010. The increase in total revenue in the second quarter of 2011 included a decline in other revenue due to certain milestone payments earned in the second quarter of 2010.

29 Jul 2011

Reprogrammed kidney cells could make transplants and dialysis things of the past

Approximately 60 million people across the globe have chronic kidney disease (CKD), and many will need dialysis or a transplant. Breakthrough research published in the Journal of the American Society Nephrology indicates that patients' own kidney cells can be gathered and reprogrammed.

28 Jul 2011

FDA accepts peginesatide NDA for anemia associated with CKD

Affymax, Inc. and Takeda Global Research & Development Center, Inc., U.S., today announced that the U.S. Food and Drug Administration (FDA) accepted for review the New Drug Application (NDA) for peginesatide (formerly known as Hematide™) for the treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis.

27 Jul 2011

Novel blood-cleaning procedure allows receipt of transplant from different blood type donor

St. Michael's Hospital today became the first in North America to use a novel blood-cleaning procedure for a kidney patient that will allow him to receive a transplant from a donor with a different blood type.

27 Jul 2011

Whistle-blower lawsuit alleges dialysis provider wasted drugs to boost profits

One of the nation's largest providers of kidney dialysis deliberately wasted medicine in order to reap hundreds of millions of dollars in extra payments from Medicare, a former clinic nurse and a doctor are charging in a whistle-blower lawsuit.

27 Jul 2011

First Edition: July 26, 2011

In her latest Kaiser Health News consumer column, Michelle Andrews writes: "In the controlled chaos of an hospital emergency department, ensuring that patients are pain-free and can make informed choices about their care often takes a back seat to assessing and stabilizing them and moving them through the system as fast as possible.

26 Jul 2011

Intravenous fluids appear to lower severity of kidney failure in children with E. coli infection

Infection with E. coli bacteria can wreak havoc in children, leading to bloody diarrhea, fever and kidney failure. But giving children intravenous fluids early in the course of an E. coli O157:H7 infection appears to lower the odds of developing severe kidney failure, according to researchers at Washington University School of Medicine in St. Louis and other institutions.

25 Jul 2011

AMAG enters definitive merger agreement with Allos Therapeutics

AMAG Pharmaceuticals, Inc. and Allos Therapeutics, Inc. today announced that they have entered into a definitive merger agreement under which the companies will combine in an all-stock merger with a total equity value of approximately $686 million.

21 Jul 2011

Millennium submits VELCADE sNDA to FDA to add OS data for previously untreated multiple myeloma

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today announced the submission of a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration for VELCADE® (bortezomib) for injection to add overall survival data after a five-year follow up to the product label.

20 Jul 2011

DaVita's catheter-reduction program lowers CVC rates in hemodialysis patients

DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), today announced that the company has made landmark progress in reducing "Day 90+" patient central venous catheter (CVC) rates, further cementing its position as the industry leader among large dialysis organizations in catheter reductions through the placement of permanent accesses.

14 Jul 2011

CMS issues proposed Medicare payment rules

The measure would increase hospital outpatient rates, dramatically cut physician payments and link surgical center payment to quality.

6 Jul 2011

ASN President discusses latest information about diabetic nephropathy at ADA

ASN President Dr. Joseph V. Bonventre, MD, PhD, spoke at the American Diabetes Association's annual meeting, 71st Scientific Session, this June in San Diego. Dr. Bonventre was featured at a symposium entitled "New Concepts in Diagnosing and Treating Diabetic Nephropathy."

6 Jul 2011

Intravenous nutrition does not have a positive effect if administered early

Critically ill patients receive intravenous nutrition - via an infusion in a large vein - when nutrition via a stomach or intestinal tube is insufficient. There is international dispute over the correct timing of intravenous nutrition: European guidelines recommend administering intravenous nutrition within 48 hours to prevent malnutrition.

1 Jul 2011

Hemova device can reduce risk of infection, clotting and vessel narrowing in dialysis patients

Johns Hopkins University graduate students have invented a device to reduce the risk of infection, clotting and narrowing of the blood vessels in patients who need blood-cleansing dialysis because of kidney failure.

30 Jun 2011

Relypsa initiates dosing in RLY5016 Phase 2b trial for hyperkalemia in diabetic nephropathy and CKD patients

Relypsa, Inc. today announced the start of dosing in a Phase 2b clinical trial of RLY5016 for the treatment of hyperkalemia in patients with diabetic nephropathy and chronic kidney disease (CKD). RLY5016 is a high capacity, non-absorbed, polymer-based potassium binder that is orally administered and has been shown to control serum potassium levels in previous studies.

28 Jun 2011

Dialysis News and Research

Latest Dialysis News and Research

CMS unveils updated website to help consumers compare quality data

Pre-emptive insulin therapy reduces risk of diabetes mellitus after kidney transplantation

NxStage second quarter revenue increases 22% to $53.8 million

Roundup: Atlanta hospital facing questions about extending dialysis care to immigrants; Fla. to limit HMO choices for state workers

Study shows fall in blood pressure during dialysis for patients increases risk of blood clotting

Amgen reports 8% increase in second quarter total product sales to $3,893 million

Reprogrammed kidney cells could make transplants and dialysis things of the past

FDA accepts peginesatide NDA for anemia associated with CKD

Novel blood-cleaning procedure allows receipt of transplant from different blood type donor

Whistle-blower lawsuit alleges dialysis provider wasted drugs to boost profits

First Edition: July 26, 2011

Intravenous fluids appear to lower severity of kidney failure in children with E. coli infection

AMAG enters definitive merger agreement with Allos Therapeutics

Millennium submits VELCADE sNDA to FDA to add OS data for previously untreated multiple myeloma

DaVita's catheter-reduction program lowers CVC rates in hemodialysis patients

CMS issues proposed Medicare payment rules

ASN President discusses latest information about diabetic nephropathy at ADA

Intravenous nutrition does not have a positive effect if administered early

Hemova device can reduce risk of infection, clotting and vessel narrowing in dialysis patients

Relypsa initiates dosing in RLY5016 Phase 2b trial for hyperkalemia in diabetic nephropathy and CKD patients

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Dialysis News and Research

Latest Dialysis News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in